Waters lands FDA clearance for at-home cervical cancer screening kit
The US Food and Drug Administration (FDA) has cleared Waters Corporation’s Onclarity human papillomavirus (HPV) self-collection kit in a development…
All articles by Ross Law
Ross Law
Ross Henry Law is a reporter for Medical Device Network. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer's disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.
-
-
Medline hit with FDA warning letter over angiographic syringe manufacturing failures
The US Food and Drug Administration (FDA) has issued a warning to Medline over deficiencies relating to the company’s angiographic…
-
CorTec gains FDA breakthrough designation for stroke rehabilitation BCI
CorTec’s brain-computer interface (BCI) has obtained breakthrough device designation from the US Food and Drug Administration (FDA) for use in…
-
FDA approves Endospan’s aortic stent
Israel’s Endospan has received US Food and Drug Administration (FDA) approval for the NEXUS aortic graft stent system, priming the…
-
E2 raises $80m to advance VTE system’s commercialisation
Endovascular Engineering (E2) has raised $80m to advance commercialisation efforts for Hēlo, a platform for venous thromboembolism (VTE) treatment. The…
-
TRiCares gains FDA IDE to initiate tricuspid regurgitation treatment pivotal trial
TRiCares has been granted an investigational device exemption (IDE) by the US Food and Drug Administration (FDA) to initiate a…
-
Beacon Biosignals raises $97m to advance EEG headband
Beacon Biosignals has raised $97m to advance development of its electroencephalogram (EEG) recording technology in areas including precision medicine and…
-
StairMed raises $73m to advance BMI and DBS system development
China’s StairMed Technology has raised RMB 500 million ($72.7m) to advance its brain-machine interface (BMI) and deep-brain stimulation (DBS) technologies…
-
Podcast: the conflict in the Middle East’s impact on the medtech supply chain
On 28 February 2026, The US and Israel initiated a war with Iran. Since then, Iran has responded by closing…
-
VDYNE secures FDA IDE to initiate pivotal trial for tricuspid regurgitation treatment
The US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to VDYNE, clearing the way for…